MeSH Browser

MeSH Heading: CD13 Antigens
Tree Number(s): D08.811.277.656.350.100.160; D08.811.277.656.350.555.100; D08.811.277.656.675.555.100; D23.050.301.264.894.113; D23.101.100.894.113
Unique ID: D018826
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D018826
Scope Note: Zinc-binding metalloproteases that are members of the type II integral membrane metalloproteases. They are expressed by GRANULOCYTES; MONOCYTES; and their precursors as well as by various non-hematopoietic cells. They release an N-terminal amino acid from a peptide, amide or arylamide.
Entry Term(s): ANPEP Protein; Alanine Aminopeptidase; Alanyl Aminopeptidase; Amino-oligopeptidase; Aminooligopeptidase; Aminopeptidase M; Aminopeptidase N; Antigens, CD13; CD13 Antigen; Membrane Alanyl Aminopeptidase
Related Numbers: 9054-63-1; EC 3.4.11.2
Previous Indexing: Alanine (1975-1980); Aminopeptidases (1981-1994); Antigens, CD (1991-1994); Antigens, Differentiation (1988); Antigens, Differentiation, Myelomonocytic (1989-1994)
Public MeSH Note: 2018; see ANTIGENS, CD13 1995-2017, CD13 ANTIGEN 1988-94, and ALANINE AMINOPEPTIDASE 1975-94; CD13 ANTIGENS was indexed under ANTIGENS, CD 1991-94; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC 1989-94; and ANTIGENS, DIFFERENTIATION 1988; ALANINE AMINOPEPIDASE was indexed under AMINOPEPTIDASES 1981-94 and under ALANINE 1975-80
History Note: 2018 (1975)
Date Established: 1995/01/01
Date of Entry: 1994/05/27
Revision Date: 2021/07/01

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

analysis (AN)

antagonists & inhibitors (AI)

biosynthesis (BI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

deficiency (DF)

drug effects (DE)

economics (EC)

genetics (GE)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

physiology (PH)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

ultrastructure (UL)

urine (UR)

Concept UI: M0028180
Related Numbers: 9054-63-1; EC 3.4.11.2
Scope Note: Zinc-binding metalloproteases that are members of the type II integral membrane metalloproteases. They are expressed by GRANULOCYTES; MONOCYTES; and their precursors as well as by various non-hematopoietic cells. They release an N-terminal amino acid from a peptide, amide or arylamide.
Terms: CD13 Antigens Preferred Term
Term UI T056118
Date04/07/1994
LexicalTag NON
ThesaurusID NLM (1995); ANPEP Protein
Term UI T001104849
Date04/19/2021
LexicalTag ACX
ThesaurusID NLM (2022); Alanine Aminopeptidase
Term UI T056116
Date04/07/1994
LexicalTag NON
ThesaurusID NLM (1995); CD13 Antigen
Term UI T056117
Date04/07/1994
LexicalTag NON
ThesaurusID NLM (1995); Antigens, CD13
Term UI T056119
Date01/01/1999
LexicalTag ACX
ThesaurusID NLM (1995); Alanyl Aminopeptidase
Term UI T056120
Date04/21/1994
LexicalTag NON
ThesaurusID NLM (1995); Aminopeptidase N
Term UI T056121
Date04/07/1994
LexicalTag NON
ThesaurusID NLM (1995); Membrane Alanyl Aminopeptidase
Term UI T056122
Date04/28/1994
LexicalTag NON
ThesaurusID NLM (1995); Aminopeptidase M
Term UI T363591
Date11/08/1999
LexicalTag NON
ThesaurusID NLM (2000)

CD13 Antigens MeSH Descriptor Data 2024